Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.36 is 35% above its 5-year average of 9.92, near the high end of its 5-year range (3.61–15.99).
As of the fiscal period ended Tuesday, June 30, 2026. 14.87% above its 12-month average of 11.63.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.36.
CURRENT RATIO
13.36
CURRENT RATIO AVG TTM
11.63
CURRENT RATIO AVG 3Y
9.53
CURRENT RATIO AVG 5Y
9.92
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+14.87%
CURRENT VS 3Y AVG
+40.23%
CURRENT VS 5Y AVG
+34.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 746 covered companies
CURRENT VS SECTOR MEDIAN
+273.25%
vs the sector median at left
Market Cap
$159.09M
Current Ratio
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$169.85M
Current Ratio
3.52
TTM Avg
3.66
3Y Avg
3.27
5Y Avg
3.06
Market Cap
$155.86M
Current Ratio
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $162.89M | 13.36 | 11.63 | 9.53 | 9.92 |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | 1.77 | 1.33 | 1.71 | 2.63 |
| Quanterix Corporation (QTRX)vs › | $164.16M | 3.40 | 5.75 | 8.37 | 8.52 |
| OptimizeRx Corp. (OPRX)vs › | $165.58M | 5.58 | 2.96 | 5.18 | 6.05 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.09M | 20.14 | 22.07 | 21.46 | 19.43 |
| Inogen, Inc. (INGN)vs › | $158.12M | 2.74 | 2.77 | 3.26 | 3.97 |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | 3.52 | 3.66 | 3.27 | 3.06 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | 0.45 | 0.24 | 0.20 | 0.38 |
| MediWound Ltd. (MDWD)vs › | $171.62M | 2.32 | 2.15 | 3.17 | 2.88 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | 9.71 | 4.67 | 6.04 | 19.74 |
Current Ratio
13.36
Quick Ratio
13.36
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.36 |
| 2026-03-31 | 14.98 |
| 2025-12-31 | 11.94 |
| 2025-09-30 | 13.15 |
| 2025-06-30 | 4.74 |
| 2025-03-31 | 4.95 |
| 2024-12-31 | 7.41 |
| 2024-09-30 | 8.47 |
| 2024-06-30 | 7.45 |
| 2024-03-31 | 15.78 |
| 2023-12-31 | 6.43 |
| 2023-09-30 | 6.35 |
| 2023-06-30 | 8.88 |
| 2023-03-31 | 9.35 |
| 2022-12-31 | 9.88 |
| 2022-09-30 | 13.16 |
| 2022-06-30 | 11.01 |
| 2022-03-31 | 7.79 |
| 2021-12-31 | 13.56 |
| 2021-09-30 | 15.99 |
| 2021-06-30 | 3.61 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
